CLDX logo

Celldex Therapeutics, Inc. (CLDX) Gross Margin

Annual Gross Margin:

54.74%-1.56%(-2.77%)
December 31, 2024

Summary

  • As of today, CLDX annual gross profit margin is 54.74%, with the most recent change of -1.56% (-2.77%) on December 31, 2024.
  • During the last 3 years, CLDX annual gross margin has risen by +20.70% (+60.81%).
  • CLDX annual gross margin is now -47.64% below its all-time high of 104.55%, reached on April 30, 1987.

Performance

1-Year Change

-2.77%

3-Year Change

+60.81%

5-Year Change

+100%

15-Year Change

+100%

CLDX Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

49.41%
CLDX annual gross profit margin is higher than 49.41% of companies in Healthcare sector

Range

All-Time High

104.55%
CLDX annual gross profit margin is currently -47.64% below its historical high of 104.55%

3-Year Low

34.04%
CLDX annual gross profit margin is currently +60.81% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
CLDX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
CLDX next annual earnings announcement has not yet been scheduled

OtherCLDXprofitability metrics

Annual Revenue

$7.02M
CLDX annual revenue is $7.02 million

Annual Gross Profit

$3.84M
CLDX annual gross profit is $3.84 million

Annual Operating Margin

-2778.89%
CLDX annual operating profit margin is -2778.89%

Annual Net Margin

-2248.76%
CLDX annual net profit margin is -2248.76%

Quarterly Gross Margin:

-19.59%+5.16%(+20.85%)
June 30, 2025

Summary

  • As of today, CLDX quarterly gross profit margin is -19.59%, with the most recent change of +5.16% (+20.85%) on June 30, 2025.
  • Over the past year, CLDX quarterly gross margin has dropped by -87.68% (-128.77%).
  • CLDX quarterly gross margin is now -106.53% below its all-time high of 300.00%, reached on September 30, 1996.

Performance

3-Month Change

+20.85%

1-Year Change

-128.77%

3-Year Change

+94.48%

5-Year Change

-100%

CLDX Quarterly Gross Margin Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

10.77%
CLDX quarterly gross profit margin is higher than 10.77% of companies in Healthcare sector

Range

All-Time High

300.00%
CLDX quarterly gross profit margin is currently -106.53% below its historical high of 300.00%

3-Year Low

-396.79%
CLDX quarterly gross profit margin is currently +95.06% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
CLDX previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 5, 2025
CLDX next earnings announcement is scheduled for Nov 5, 2025

OtherCLDXprofitability metrics

Quarterly Revenue

$730.00K
CLDX quarterly revenue is $730.00 thousand

Quarterly Gross Profit

-$143.00K
CLDX quarterly gross profit is -$143.00 thousand

Quarterly Operating Margin

-8747.53%
CLDX quarterly operating profit margin is -8747.53%

Quarterly Net Margin

-7753.42%
CLDX quarterly net profit margin is -7753.42%

Gross Margin Formula

Gross Margin =  Gross Profit
Revenue ✕ 100%

Annual Gross Margin

54.74%
CLDX annual gross profit margin is 54.74%

Annual Gross Profit

$3.84M
CLDX annual gross profit is $3.84 million

Annual Revenue

$7.02M
CLDX annual revenue is $7.02 million

CLDX Gross Margin Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year-2.8%-128.8%
3Y3 Years+60.8%+94.5%
5Y5 Years+100.0%-100.0%

CLDX Gross Margin Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-2.8%+60.8%-124.0%+95.1%
5Y5-Year-2.8%>+9999.0%-124.0%+95.1%
All-TimeAll-Time-47.6%+175.8%-106.5%+95.7%

CLDX Gross Margin History

DateAnnualQuarterly
Jun 2025
-
-19.59%(+20.8%)
Mar 2025
-
-24.75%(-181.7%)
Dec 2024
54.74%(-2.8%)
30.30%(-59.8%)
Sep 2024
-
75.37%(+10.7%)
Jun 2024
-
68.09%(+117.2%)
Mar 2024
-
-396.79%(-586.1%)
Dec 2023
56.30%(+38.7%)
81.63%(+65.1%)
Sep 2023
-
49.44%(+127.2%)
Jun 2023
-
-182.09%(-830.7%)
Mar 2023
-
24.92%(-57.2%)
Dec 2022
40.60%(+19.3%)
58.28%(+189.9%)
Sep 2022
-
-64.86%(+81.7%)
Jun 2022
-
-354.60%(>-9900.0%)
Mar 2022
-
0.00%(+100.0%)
Dec 2021
34.04%(>+9900.0%)
-132.63%(>-9900.0%)
Sep 2021
-
0.00%(0.0%)
Jun 2021
-
0.00%(0.0%)
Mar 2021
-
0.00%(0.0%)
Dec 2020
0.00%(0.0%)
0.00%(0.0%)
Sep 2020
-
0.00%(0.0%)
Jun 2020
-
0.00%(0.0%)
Mar 2020
-
0.00%(0.0%)
Dec 2019
0.00%(0.0%)
0.00%(0.0%)
Sep 2019
-
0.00%(0.0%)
Jun 2019
-
0.00%(0.0%)
Mar 2019
-
0.00%(0.0%)
Dec 2018
0.00%(0.0%)
0.00%(0.0%)
Sep 2018
-
0.00%(0.0%)
Jun 2018
-
0.00%(0.0%)
Mar 2018
-
0.00%(0.0%)
Dec 2017
0.00%(0.0%)
0.00%(0.0%)
Sep 2017
-
0.00%(0.0%)
Jun 2017
-
0.00%(0.0%)
Mar 2017
-
0.00%(0.0%)
Dec 2016
0.00%(-100.0%)
0.00%(0.0%)
Sep 2016
-
0.00%(0.0%)
Jun 2016
-
0.00%(0.0%)
Mar 2016
-
0.00%(-100.0%)
Dec 2015
26.81%(+419.6%)
38.58%(>+9900.0%)
Sep 2015
-
0.00%(0.0%)
Jun 2015
-
0.00%(0.0%)
Mar 2015
-
0.00%(-100.0%)
Dec 2014
5.16%(+118.2%)
40.62%(+83.3%)
Sep 2014
-
22.16%(+153.8%)
Jun 2014
-
-41.22%(+58.8%)
Mar 2014
-
-100.00%(-333.7%)
Dec 2013
-28.41%(-379.9%)
-23.06%(-191.5%)
Sep 2013
-
25.20%(>+9900.0%)
Jun 2013
-
0.00%(+100.0%)
Mar 2013
-
-7.17%(-65.6%)
Dec 2012
-5.92%(+69.0%)
-4.33%(+8.3%)
Sep 2012
-
-4.72%(+38.9%)
Jun 2012
-
-7.72%(+98.3%)
Mar 2012
-
-450.92%(-9.3%)
Dec 2011
-19.07%(-130.9%)
-412.45%(>-9900.0%)
Sep 2011
-
0.00%(0.0%)
Jun 2011
-
0.00%(0.0%)
Mar 2011
-
0.00%(-100.0%)
Dec 2010
61.67%(>+9900.0%)
61.41%(+120.9%)
Sep 2010
-
-294.31%(-17.4%)
Jun 2010
-
-250.59%(-24.4%)
Mar 2010
-
-201.45%(>-9900.0%)
Dec 2009
0.00%(0.0%)
0.00%(0.0%)
Sep 2009
-
0.00%(0.0%)
Jun 2009
-
0.00%(0.0%)
Mar 2009
-
0.00%(0.0%)
Dec 2008
0.00%(0.0%)
0.00%(0.0%)
Sep 2008
-
0.00%(0.0%)
Jun 2008
-
0.00%(+100.0%)
Mar 2008
-
-172.73%(-448.1%)
Dec 2007
0.00%
49.62%(>+9900.0%)
Sep 2007
-
0.00%(0.0%)
Jun 2007
-
0.00%(0.0%)
DateAnnualQuarterly
Mar 2007
-
0.00%(0.0%)
Dec 2006
0.00%(0.0%)
0.00%(0.0%)
Sep 2006
-
0.00%(0.0%)
Jun 2006
-
0.00%(0.0%)
Mar 2006
-
0.00%(0.0%)
Dec 2005
0.00%(0.0%)
0.00%(0.0%)
Sep 2005
-
0.00%(0.0%)
Jun 2005
-
0.00%(0.0%)
Mar 2005
-
0.00%(0.0%)
Dec 2004
0.00%(0.0%)
0.00%(0.0%)
Sep 2004
-
0.00%(0.0%)
Jun 2004
-
0.00%(0.0%)
Mar 2004
-
0.00%(0.0%)
Dec 2003
0.00%(-100.0%)
0.00%(0.0%)
Sep 2003
-
0.00%(0.0%)
Jun 2003
-
0.00%(0.0%)
Mar 2003
-
0.00%(0.0%)
Dec 2002
75.20%(+139.2%)
0.00%(-100.0%)
Sep 2002
-
91.07%(+160.5%)
Jun 2002
-
34.96%(-2.6%)
Mar 2002
-
35.88%(+4.1%)
Dec 2001
31.44%(+143.5%)
34.48%(+43.0%)
Sep 2001
-
24.11%(-20.3%)
Jun 2001
-
30.26%(-14.6%)
Mar 2001
-
35.45%(+215.1%)
Dec 2000
-72.21%(>-9900.0%)
-30.80%(>-9900.0%)
Sep 2000
-
0.00%(0.0%)
Jun 2000
-
0.00%(0.0%)
Mar 2000
-
0.00%(0.0%)
Dec 1999
0.00%(-100.0%)
-
Sep 1999
-
0.00%(0.0%)
Jun 1999
-
0.00%(0.0%)
Mar 1999
-
0.00%(0.0%)
Dec 1998
52.93%(-22.8%)
0.00%(-100.0%)
Sep 1998
-
38.22%(-44.7%)
Jun 1998
-
69.12%(-4.6%)
Mar 1998
-
72.44%(-63.8%)
Dec 1997
68.56%(+162.5%)
-
Sep 1997
-
200.00%(+75.0%)
Jun 1997
-
114.29%(-42.9%)
Mar 1997
-
200.00%(-33.3%)
Dec 1996
26.12%(-50.3%)
-
Sep 1996
-
300.00%(+100.0%)
Jun 1996
-
150.00%(+125.0%)
Mar 1996
-
66.67%(-14.3%)
Dec 1995
52.58%(-26.1%)
77.78%(+55.6%)
Sep 1995
-
50.00%(-25.0%)
Jun 1995
-
66.67%(-11.1%)
Mar 1995
-
75.00%(+7.1%)
Dec 1994
71.18%(-14.6%)
70.00%(-12.5%)
Sep 1994
-
80.00%(-2.2%)
Jun 1994
-
81.82%(-5.9%)
Mar 1994
-
86.96%(+12.5%)
Dec 1993
83.33%(-8.3%)
77.27%(-9.8%)
Sep 1993
-
85.71%(-3.1%)
Jun 1993
-
88.46%(+2.4%)
Mar 1993
-
86.36%(-10.6%)
Dec 1992
90.91%(+3.7%)
-
Oct 1992
-
96.55%(+15.9%)
Jul 1992
-
83.33%(-9.1%)
Apr 1992
-
91.67%(+1.5%)
Apr 1992
87.64%(-1.8%)
-
Jan 1992
-
90.32%(+9.7%)
Oct 1991
-
82.35%(0.0%)
Jul 1991
-
82.35%(-2.0%)
Apr 1991
89.22%(-3.7%)
84.00%(-5.0%)
Jan 1991
-
88.46%(-4.2%)
Oct 1990
-
92.31%(+4.9%)
Jul 1990
-
88.00%(-6.5%)
Apr 1990
92.66%(+3.3%)
94.12%(+2.9%)
Jan 1990
-
91.43%
Apr 1989
89.74%(-4.0%)
-
Apr 1988
93.48%(-10.6%)
-
Apr 1987
104.55%
-

FAQ

  • What is Celldex Therapeutics, Inc. annual gross profit margin?
  • What is the all-time high annual gross margin for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. annual gross margin year-on-year change?
  • What is Celldex Therapeutics, Inc. quarterly gross profit margin?
  • What is the all-time high quarterly gross margin for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. quarterly gross margin year-on-year change?

What is Celldex Therapeutics, Inc. annual gross profit margin?

The current annual gross margin of CLDX is 54.74%

What is the all-time high annual gross margin for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high annual gross profit margin is 104.55%

What is Celldex Therapeutics, Inc. annual gross margin year-on-year change?

Over the past year, CLDX annual gross profit margin has changed by -1.56% (-2.77%)

What is Celldex Therapeutics, Inc. quarterly gross profit margin?

The current quarterly gross margin of CLDX is -19.59%

What is the all-time high quarterly gross margin for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high quarterly gross profit margin is 300.00%

What is Celldex Therapeutics, Inc. quarterly gross margin year-on-year change?

Over the past year, CLDX quarterly gross profit margin has changed by -87.68% (-128.77%)
On this page